Superior vena cava syndrome epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Superior vena cava syndrome}} | {{Superior vena cava syndrome}} | ||
{{CMG}} | {{CMG}}{{AE}}{{MV}} | ||
==Overview== | |||
Superior vena cava syndrome is a common oncologic emergency. The incidence rate in the United States of SVCS is approximately 15,000 individuals each year. The incidence of superior vena cava syndrome increases with age; SVCS affects adults with more frequency, and it is less common in children and young adults. The median age of diagnosis is between 40-60 years. Males are slightly more affected than women. | |||
==Epidemiology and demographics== | |||
===Prevalence=== | |||
*The prevalence of SVCS remains unknown. | |||
===Incidence=== | |||
*In the United States, the incidence of superior vena cava syndrome is 15,000 each year | |||
===Gender=== | |||
*Males are more commonly affected than females because of the high incidence of lung cancer among patients with SVCS. | |||
===Race=== | |||
*The prevalence of SVCS does not vary by race. However, depending on the type of cancer a racial predilection may be possible. | |||
==References== | ==References== | ||
| Line 12: | Line 26: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Intensive care medicine]] | [[Category:Intensive care medicine]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 20:25, 11 January 2016
|
Superior Vena Cava Syndrome Microchapters |
|
Differentiating Superior Vena Cava Syndrome from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Superior vena cava syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Superior vena cava syndrome epidemiology and demographics |
|
FDA on Superior vena cava syndrome epidemiology and demographics |
|
CDC on Superior vena cava syndrome epidemiology and demographics |
|
Superior vena cava syndrome epidemiology and demographics in the news |
|
Blogs on Superior vena cava syndrome epidemiology and demographics |
|
Directions to Hospitals Treating Superior vena cava syndrome |
|
Risk calculators and risk factors for Superior vena cava syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Superior vena cava syndrome is a common oncologic emergency. The incidence rate in the United States of SVCS is approximately 15,000 individuals each year. The incidence of superior vena cava syndrome increases with age; SVCS affects adults with more frequency, and it is less common in children and young adults. The median age of diagnosis is between 40-60 years. Males are slightly more affected than women.
Epidemiology and demographics
Prevalence
- The prevalence of SVCS remains unknown.
Incidence
- In the United States, the incidence of superior vena cava syndrome is 15,000 each year
Gender
- Males are more commonly affected than females because of the high incidence of lung cancer among patients with SVCS.
Race
- The prevalence of SVCS does not vary by race. However, depending on the type of cancer a racial predilection may be possible.